Both PU.1 and Nuclear factor-κB mediate lipopolysaccharide-induced HIV- 1 long terminal repeat transcription in macrophages

Journal of Immunology

Volumn 161, Issue 1, 1998, Pages 268-276

  Lodie, Tracey A ^a   Reiner, Marshall ^a   Coniglio, Salvatore ^a   Viglianti, Gregory ^a   Fenton, Matthew J ^a,b  

^a BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Boston University Medical Campus   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LIPOPOLYSACCHARIDE; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR PU 1; UNCLASSIFIED DRUG;

ARTICLE; BINDING AFFINITY; BINDING SITE; DNA BINDING; DNA FLANKING REGION; GENE ACTIVATION; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; LONG TERMINAL REPEAT; MACROPHAGE; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; REPORTER GENE; SITE DIRECTED MUTAGENESIS; TRANSCRIPTION REGULATION;

ANIMALS; BINDING SITES; CELL LINE; CELL LINE, TRANSFORMED; GENE EXPRESSION REGULATION; HIV LONG TERMINAL REPEAT; HUMANS; LIPOPOLYSACCHARIDES; MACROPHAGE ACTIVATION; MACROPHAGES; MICE; MUTAGENESIS, SITE-DIRECTED; NF-KAPPA B; PROMOTER REGIONS (GENETICS); PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-ETS; RECEPTORS, INTERLEUKIN-2; SERINE; TRANS-ACTIVATORS; TRANSCRIPTION FACTOR RELB; TRANSCRIPTION FACTORS; TRANSCRIPTION, GENETIC;

EID: 0031803277     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (39)

1. Pomerantz, R. J., M. B. Feinberg, D. Trono, and D. Baltimore. 1990. Lipopolysaccharide is a potent monocyte/macrophage-specific stimulator of human immunodeficiency virus type 1 expression. J. Exp. Med. 172:253.
2. Vicenzi, E., and G. Poli. 1994. Regulation of HIV expression by viral genes and cytokines. J. Leukocyte Biol. 56:328.
3. Nabel, G. J., and D. Baltimore. 1987. An inducible transcription factor activates expression of human immunodeficiency virus in T cells. Nature 326:711.
4. Osborn, L., S. Kunkel, and G. J. Nabel. 1989. Tumor necrosis factor alpha and interleukin 1 stimulate the human immunodeficiency virus enhancer by activation of the nuclear factor kappa B. Proc. Natl. Acad. Sci. USA 86:2336.
5. Majello, B., P. De Luca, G. Hagen, G. Suske, and L. Lania. 1994. Different members of the Sp1 multigene family exert opposite transcriptional regulation of the long terminal repeat of HIV-1. Nucleic Acids Res. 22:4914.
6. Perkins, N. D., A. B. Agranoff, E. Pascal, and G. J. Nabel. 1994. An interaction between the DNA-binding domains of RelA(p65) and Sp1 mediates human immunodeficiency virus gene activation. Mol. Cell. Biol. 14:6570.
7. Henderson, A. J., X. Zou, and K. L. Calame. 1995. C/EBP proteins activate transcription from the human immunodeficiency virus type 1 long terminal repeat in macrophages/monocytes. J. Virol. 69:5337.
8. Henderson, A. J., R. I. Connor, and K. L. Calame. 1996. C/EBP activators are required for HIV-1 replication and proviral induction in monocytic cell lines. Immunity 5:91.
9. Baeuerle, P. A., and T. Henkel. 1994. Function and activation of NF-κB in the immune system. Annu. Rev. Immunol. 12:141.
10. Zeichner, S. L., J. Y. Kim, and J. C. Alwine. 1991. Linker-scanning mutational analysis of the transcriptional activity of the human immunodeficiency virus type 1 long terminal repeat. J. Virol. 65:2436.
11. Phares, W., B. R. Franza, and W. Herr. 1992. The κB enhancer motif in human immunodeficiency virus type 1 and SV40 recognize different binding activities in human Jurkat and H9 T cells: evidence for NF-κB-independent activation of the κB motif. J. Virol. 66:7490.
12. Conant, K., W. J. Atwood, R. Traub, C. Tornatore, and E. O. Major. 1994. An increase in p50/p65 NF-κB binding to the HIV-1 LTR is not sufficient to increase viral expression in the primary human astrocyte. Virology 205:586.
13. Seth, A., D. R. Hodge, D. M. Thompson, L. Robinson, A. Panayiotakis, D. K. Watson, and T. S. Papas. 1993. ETS family proteins activate transcription from HIV-1 long terminal repeat. AIDS Res. Hum. Retroviruses 9:1017
14. Bassuk, A. G., R. T. Anandappa, and J. M. Leiden. 1997. Physical interactions between Ets and NF-κB/NFAT proteins play an important role in their cooperative activation of the human immunodeficiency virus enhancer in T cells. J. Virol. 71:3563.
15. Flory, E., A. Hoffmeyer, U. Smola, U. Rapp, and J. Bruder. 1996. Raf-1 kinase targets GA-binding protein in transcriptional regulation of the human immunodeficiency virus type 1 promoter. J. Virol. 70:2260.
16. Moreau-Gachelin, F. 1994. Spi-1/PU.1: an oncogene of the Ets family. Biochim. Biophys. Acta 1198:149.
17. Pongubala, J. M. R., S. Nagulapalli, M. J. Klemsz, S. R. McKercher, R. A. Maki, and M. L. Atchison. 1992. PU.l recruits a second nuclear factor to a site important for immunoglobulin κ 3′ enhancer activity. Mol. Cell. Biol. 12:368.
18. Pongubala, J. M. R., C. Van Beveren, S. Nagulapalli, M. J. Klemsz, S. R. McKercher, R. A. Maki, and M. L. Atchison. 1993. Effect of PU.1 phosphorylation on interaction with NF-EM5 and transcriptional activation. Science 259:1662.
19. Buras, J. A., W. R. Reensta, and M. J. Fenton. 1995. The NFβA. a factor required for maximal IL-1βgene expression is identical to the ets family member PU.1: evidence for structural alteration following LPS activation. Mol. Immunol. 32:541.
20. Lodie, T. A., R. Savedra, D. T. Golenbock, C. P. Van Beveren, R. A. Maki, and M. J. Fenton. 1997. Stimulation of macrophages by lipopolysaccharide alters the phosphorylation state, conformation, and function of PU.1 via activation of casein kinase II. J. Immunol. 158:1848.
21. Delude, R. L., R. Savedra, H. Zhao, R. Thieringer, S. Yamamoto, M. J. Fenton, and D. T. Golenbock. 1995. CD14 enhances cellular responses to endotoxin without imparting ligand-specific recognition. Proc. Natl. Acad. Sci. USA 92:9288.
22. Lin, R., P. Beauparlant, C. Makris, S. Meloche, and J. Hiscott. 1996. Phosphorylation of IκBα in the C-terminal PEST domain by CKII affects intrinsic protein stability. Mol. Cell. Biol. 16:1401.
23. Southgate, C. D., and M. R. Green. 1991. The HIV-1 Tat protein activates transcription from an upstream DNA-binding site: implications for Tat function. Genes Dev. 5:2496.
24. Leonard, J., C. Parrott, A. J. Buckler-White, W. Turner, E. K. Ross, M. A. Martin, and A. B. Rabson. 1989. The NF-κB binding sites in the human immunodeficiency virus type 1 long terminal repeat are not required for virus infectivity. J. Virol. 63:4919.
25. Lowenthal, J. W., E. Bohnlein, D. W. Ballard, and W. C. Greene. 1988. Regulation of interleukin 2 receptor a subunit (Tac or CD25 antigen) gene expression: binding of inducible nuclear proteins to discrete promoter sequences correlates with transcriptional activation. Proc. Natl. Acad. Sci. USA 85:4468.
26. Viglianti, G. A., and J. I. Mullins. 1988. Functional comparison of transactivation by simian immunodeficiency virus from rhesus macaques and human immunodeficiency virus type 1. J. Virol. 62:4523.
27. Andersson, S., D. L. Davis, H. Dahlback, H. Jornvall, and D. W. Russell. 1989. Cloning, structure, and expression of the mitochondrial cytochrome P-450 sterol 26-hydroxylase, a bile acid biosynthetic enzyme. J. Biol. Chem. 264:8222.
28. Langer, S. J., and M. C. Ostrowski. 1988. Negative regulation of transcription in vitro by a glucocorticoid response element is mediated by a trans-acting factor. Mol. Cell. Biol. 8:3872.
29. Buras, J. A., B. G. Monks, and M. J. Fenton. 1994. The NFβA-binding element, not an overlapping NF-IL6-binding element, is required for maximal IL-1β gene expression. J. Immunol. 152:4444.
30. Savedra, R., R. L. Delude, R. R. Ingalls, M. J. Fenton, and D. T. Golenbock. 1996. Mycobacterial lipoarabinomannan recognition requires a receptor that shares components of the endotoxin signaling system. J. Immunol. 157:2549.
31. Gaynor, R. B., M. D. Kuwabara, F. K. Wu, J. A. Garcia, D. Harrich, M. Briskin, R. Wall, and D. S. Sigman. 1988. Repeated B motifs in the human immunodeficiency virus type I long terminal repeat enhancer region do not exhibit cooperative factor binding. Proc. Natl. Acad. Sci. USA 85:9406.
32. Sweet, M. J., K. J. Stacey, I. L. Ross, M. C. Ostrowski, and D. A. Hume. 1998. The involvement of Ets, Rel, and Spl-like proteins in the lipopolysaccharide-mediated activation of the HIV-1-LTR in macrophages. J. Inflamm. In press.
33. Doerre, S., S. Prakash, S. Shao-Cong, D. W. Ballard, and W. C. Greene. 1993. The c-rel protooncogene product represses NF-κB p65-mediated transeriptional activation of the long terminal repeat of type 1 human immunodeficiency virus. Proc. Natl. Acad. Sci. USA 90:1023.
34. Baldwin, A. S., and P. A. Sharp. 1988. Two transcription factors, NF-βB and H2TF1, interact with a single regulatory sequence in the class I major histocompatibility complex promoter. Proc. Natl. Acad. Sci. USA 85:723.
35. Hunninghake, G. W., B. G. Monks, L. J. Geist, M. M. Monick, M. A. Monroy, M. F. Stinski, A. C. Webb, J. M. Dayer, P. E. Auron, and M. J. Fenton. 1992. The functional importance of a cap site-proximal region of the human prointerleukin 1β gene is defined by viral trans-activation. Mol. Cell. Biol. 12:3439.
36. Critchfield, J. W., J. E. Coligan, T. M. Folks, and S. T. Butera. 1997. Casein kinase II is a selective target of HIV-1 transcriptional inhibitors. Proc. Natl. Acad. Sci. USA 94:6110.
37. Carvalho, M., and D. Derse. 1993. The PU.1/Spi-1 proto-oncogene is a transcriptional regulator of a lentivirus promoter. J. Virol. 67:3885.
38. Kornbluth, R. S., P. S. Oh, J. R. Munis, P. H. Cleveland, and D. D. Richman. 1989. Interferons and bacterial lipopolysaccharide protect macrophages from productive infection by human immunodeficiency virus in vitro. J. Exp. Med. 169:1137.
39. Bernstein, M. S., S. E. Tong-Starksen, and R. M. Locksley. 1991. Activation of human monocyte derived macrophages with LPS decreases human immunodeficiency virus replication in vitro at the level of gene expression. J. Clin. Invest. 88:540.